ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
GI toxicity hits midstage Sanofi GLP-1 drug as patients drop out
fiercebiotech
April 28, 2018Sanofi said gastrointestinal concerns have made its experimental GLP-1 phase 2 drug SAR425899 “not acceptable for clinical use,” but it is undertaking new tests to try to get around dosing issues, which it blames for the AEs.
Pharma Sources Insight January 2025
